Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check5 days agoChange DetectedUpdated language and related resource/location text for Valparaiso, Chile (including regional wording) and refreshed the displayed site/release revision from v3.5.0 to v3.5.2.SummaryDifference0.3%

- Check12 days agoChange DetectedAdded a new study site in Québec, Canada (G1V 4G5) and updated the location entry. The previous listing 'Québec, Quebec, Canada, G1V 4G5' was replaced with 'Québec, Canada, G1V 4G5' to reflect a formatting update.SummaryDifference0.7%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRemoved Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center from the Resources section.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision tag updated: added Revision: v3.5.0 and removed Revision: v3.4.3. This metadata change does not modify the study content or presented data.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 added; v3.4.2 removed.SummaryDifference0.0%

- Check71 days agoChange DetectedStudy status updated from Active, not recruiting to Completed, with enrollment changing from 576 to 598 and the completion date updated to 2026-02-02. Revision updated to v3.4.2.SummaryDifference0.9%

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.